An Exploratory Clinical Study of Apatinib for the 2nd Treatment of Esophageal Cancer or Esophageal and Gastric

Clinical trial NCT03285906 · UNKNOWN

Trial details

NCT number: NCT03285906
Sponsor: Tianjin Medical University Cancer Institute and Hospital
Status: UNKNOWN
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Esophagus Cancer, Stage III Esophageal Gastric Cardia Type Metaplasia Esophagus Cancer, Stage IV

Start date: 2017-03-01
Primary completion: 2019-06-01
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.